Charco Neurotech targets Parkinson’s symptom management via vibrotactile cueing, addressing gait freezing and motor symptoms without invasive intervention. Its wearable-first approach differentiates it from pharmacological and DBS treatments, though clinical efficacy remains under validation relative to established therapies.